Skip to main content
Clinical Trials/JPRN-UMIN000041295
JPRN-UMIN000041295
Completed
未知

A verification study of the effects of consumption of ORYZA CERAMIDE on the skin barrier function using TEWL as an index: A randomized, double-blind, placebo-controlled, parallel-group trial - A verification study of the effects of consumption of ORYZA CERAMIDE on the skin barrier function using TEWL as an index

ORTHOMEDICO Inc.0 sites44 target enrollmentAugust 3, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Japanese subjects
Sponsor
ORTHOMEDICO Inc.
Enrollment
44
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2020
End Date
December 4, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects undergoing medical treatment or having a medical history of malignant tumor, heart failure, or myocardial infarction 2\. Subjects carrying a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage as part of their daily intake 5\. Subjects regularly taking medications (including herbal medicines) and supplements 6\. Subjects allergic to medications and/or the test\-food\-related products 7\. Subjects who are pregnant, lactating, or intending to become pregnant 8\. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 9\. Subjects who have got cosmetic surgery 10\. Subjects who habitually receive skincare treatment (e.g., aesthetic treatment) or use instruments for beauty treatment (e.g., facial treatment device) 11\. Subjects who use any other products except for general skin care products (a cream/essence, a skin pack, skin lotion, milky lotion, sunscreen, and these all\-in\-one products) 12\. Subjects who have been diagnosed with atopic dermatitis 13\. Subjects who are judged as ineligible to participate in the study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials